Preferential efficacy of serotonergic medication in obsessive-compulsive disorder: From practice to theory

Iulian Iancu, Pinhas N. Dannon, Michal Lustig, Yehuda Sasson, Joseph Zohar

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Until the early 1980s, obsessive-compulsive disorder (OCD) was considered a treatment-refractory, chronic condition of psychological origins. Treatment strategies included dynamic psychotherapy, which in general was of little benefit, and a variety of pharmacological treatments that had been tried without much success (Salzman & Thaler, 1981). The observation that clomipramine, a tricyclic antidepressant with a serotonergic profile, is effective in treating symptoms of OCD has resulted in intense interest in the relation between serotonin and this disorder (FemandezCordoba & Lopez-Ibor, 1967; Renynghe de Voxrie, 1968; Yaryura-Tobias, Neziroglu, & Bergman, 1976).

Original languageEnglish
Title of host publicationObsessive-Compulsive Disorder
Subtitle of host publicationContemporary Issues in Treatment
PublisherTaylor and Francis
Pages303-313
Number of pages11
ISBN (Electronic)9781317200239
ISBN (Print)0805828370, 9781138674783
DOIs
StatePublished - 1 Jan 2017

Fingerprint

Dive into the research topics of 'Preferential efficacy of serotonergic medication in obsessive-compulsive disorder: From practice to theory'. Together they form a unique fingerprint.

Cite this